×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [5]
复旦大学上海医学院 [2]
西安交通大学 [1]
昆明医科大学 [1]
中国医学科学院 北京... [1]
内容类型
期刊论文 [9]
会议论文 [1]
发表日期
2022 [4]
2021 [1]
2017 [4]
2012 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
期刊论文
THORACIC CANCER, 2022
作者:
Xu, Chunwei
;
Si, Lu
;
Wang, Wenxian
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2022/12/22
fusion
precision medicine
solid tumor
targeted therapy
tyrosine receptor kinase
A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non-small cell lung cancer (NSCLC).
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Zhou, Caicun
;
Ren, Shengxiang
;
Luo, Yongzhong
;
Wang, Lei
;
Xiong, Anwen
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2022/12/23
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:
Zhou, Qing
;
Chen, Ming
;
Jiang, Ou
;
Pan, Yi
;
Hu, Desheng
收藏
  |  
浏览/下载:118/0
  |  
提交时间:2022/03/21
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
期刊论文
THORACIC CANCER, 2021
作者:
Shi, Yuequan
;
Fang, Jian
;
Zhou, Chengzhi
;
Liu, Anwen
;
Wang, Yan
收藏
  |  
浏览/下载:70/0
  |  
提交时间:2022/01/25
advanced lung cancer
immune checkpoint inhibitors
immune-related adverse events
real-world data
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1
作者:
Zhao, Yizhuo
;
Wang, Qiming
;
Zhang, Li
;
Shi, Jianhua
;
Wang, Zhehai
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/04
NSCLC
Anlotinib
multi-targeted tyrosine kinase inhibitor
A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare).
会议论文
作者:
Zhu, Ji
;
Sun, Xinchen
;
Zhang, Tao
;
Liu, Anwen
;
Zhu, Yuan
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 页码: S886-S887
作者:
Han, Baohui
;
Li, Kai
;
Zhao, Yizhuo
;
Wang, Qiming
;
Zhang, Li
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/11/26
NSCLC
multi-targeted tyrosine kinase inhibitor
Anlotinib
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
期刊论文
2017, 卷号: 12, 期号: 1, 页码: S886-S887
作者:
Han, Baohui
;
Li, Kai
;
Zhao, Yizhuo
;
Wang, Qiming
;
Zhang, Li
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
NSCLC
Anlotinib
multi-targeted tyrosine kinase inhibitor
The effect of folic acid on ovine fetuses in utero during late gestation
期刊论文
DRUG AND CHEMICAL TOXICOLOGY, 2012, 卷号: 35, 期号: 2
作者:
Mao, Caiping
;
Liu, Yujuan
;
Jiang, Shan
;
Zhou, Anwen
;
Zhang, Peiwen
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Folic acid
gestation
ovine fetus in utero
cardiac
hepatic
renal functions
©版权所有 ©2017 CSpace - Powered by
CSpace